[A phase II pharmacological study of leuprolide acetate 6-month depot, TAP-144-SR (6M), in treatment-Nazve patients with prostatic cancer who received a single subcutaneous or intramuscular injection]. | Gan To Kagaku Ryoho;41(5): 587-93, 2014 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

[A phase II pharmacological study of leuprolide acetate 6-month depot, TAP-144-SR (6M), in treatment-Nazve patients with prostatic cancer who received a single subcutaneous or intramuscular injection].

Komura, Emiko; Fujimoto, Tsukasa; Takabayashi, Nobuyoshi; Okamoto, Hiroyuki; Akaza, Hideyuki.

Affiliation

Komura E; Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited.

Gan To Kagaku Ryoho ; 41(5): 587-93, 2014 May.

Article in Ja | MEDLINE | ID: mdl-24917003

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Leuprolide Type of study: Clinical_trials Limits: Aged / Humans / Male Language: Ja Journal: Gan To Kagaku Ryoho Year: 2014 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Leuprolide Type of study: Clinical_trials Limits: Aged / Humans / Male Language: Ja Journal: Gan To Kagaku Ryoho Year: 2014 Document type: Article